Odani, A <br/><br/>
Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Sep 1997 
 - 287-92 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/S0009-9236(97)90031-X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anticonvulsants--pharmacokinetics<br/>Aryl Hydrocarbon Hydroxylases<br/>Bayes Theorem<br/>Child<br/>Child, Preschool<br/>Cytochrome P-450 CYP2C19<br/>Cytochrome P-450 CYP2C9<br/>Cytochrome P-450 Enzyme System--chemistry<br/>Epilepsy--drug therapy<br/>Female<br/>Gene Expression Regulation, Enzymologic--genetics<br/>Genotype<br/>Heterozygote<br/>Humans<br/>Infant<br/>Japan<br/>Male<br/>Mixed Function Oxygenases--chemistry<br/>Mutation--genetics<br/>Phenytoin--blood<br/>Polymerase Chain Reaction<br/>Polymorphism, Genetic<br/>Steroid 16-alpha-Hydroxylase<br/>Steroid Hydroxylases--chemistry